GSK Tries To Halt Teva's Generic Combivir Launch
GlaxoSmithKline PLC has asked a court to block Teva Pharmaceuticals USA Inc.'s planned May launch of a generic version of GSK's HIV drug Combivir....To view the full article, register now.
Already a subscriber? Click here to view full article